Completed PHASE2 INTERVENTIONAL NCT00000204

Buprenorphine Maintenance for Opioid Addicts - 3

Buprenorphine Maintenance for Opioid Addicts

Sponsor: National Institute on Drug Abuse (NIDA)

Updated 6 times since 2017 Last updated: Apr 28, 2020 Started: Aug 31, 1988 Primary completion: May 31, 2006 Completion: May 31, 2006

This information is for research purposes only and is not medical advice. Consult a healthcare provider before making any medical decision.

This PHASE2 trial investigates Opioid-Related Disorders and is currently completed. National Institute on Drug Abuse (NIDA) leads this study, which shows 6 recorded versions since 1988 — indicating limited longitudinal coverage. The change history captured here reflects the iterative nature of clinical trial conduct.

Status Flow

Change History

6 versions recorded

Sep 2024 — Present [monthly]

Completed PHASE2
Jul 2024 — Sep 2024 [monthly]

Completed PHASE2
Jan 2021 — Jul 2024 [monthly]

Completed PHASE2
May 2020 — Jan 2021 [monthly]

Completed PHASE2
Jun 2018 — May 2020 [monthly]

Completed PHASE2

▶ Show 1 earlier version

Jan 2017 — Jun 2018 [monthly]

Completed PHASE2

First recorded

Aug 1988

Trial started

Per CT.gov start date — pre-dates our first snapshot

Eligibility Summary

No eligibility information available.

Contact Information

Sponsor contact:

National Institute on Drug Abuse (NIDA)
Yale University

Data source: Yale University

For direct contact, visit the study record on ClinicalTrials.gov .

Study Locations

• New Haven, United States